Huang, Hongli <br/><br/>
Dopamine D2 receptor suppresses gastric cancer cell invasion and migration via inhibition of EGFR/AKT/MMP-13 pathway.  [electronic resource] 

 -  International immunopharmacology  Oct 2016 
 - 113-120 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1878-1705 
<br/><br/><label>Standard No.: </label>10.1016/j.intimp.2016.07.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Carcinogenesis--drug effects<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Cell Proliferation--drug effects<br/>Dopamine--therapeutic use<br/>Epidermal Growth Factor--metabolism<br/>ErbB Receptors--metabolism<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Matrix Metalloproteinase 13--metabolism<br/>Oncogene Protein v-akt--metabolism<br/>Receptors, Dopamine D2--agonists<br/>Signal Transduction--drug effects<br/>Stomach Neoplasms--drug therapy